Clinical Trial Update: Arginine Malaria Trial: Study of Adjunctive Arginine in Falciparum Malaria [Phase 1, Phase 2]

View source ↗

Summary

The document indicates the completion of a Phase 1/Phase 2 clinical trial evaluating adjunctive L-arginine in falciparum malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: Menzies School of Health Research | Conditions: Malaria, Falciparum | Phase 1, Phase 2 | Status: COMPLETED